Snapshot

The Abridged Review pathway has been developed by the Namibia Medicines Regulatory Council (NMRC) of Namibia.

This pathway can be used where All therapeutic products..

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from Australia Brazil Canada China EU-EMA Japan Mexico Saudi Arabia Singapore South Africa South Korea Switzerland Taiwan (Chinese Taipei) Turkey United Kingdom United States WHO Zazibona Zimbabwe

270.